rs150077735
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The ENST00000311895.8(ERCC4):c.2734G>A(p.Gly912Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000658 in 1,611,460 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G912E) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000311895.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERCC4 | NM_005236.3 | c.2734G>A | p.Gly912Arg | missense_variant | 11/11 | ENST00000311895.8 | NP_005227.1 | |
ERCC4 | XM_011522424.4 | c.2872G>A | p.Gly958Arg | missense_variant | 12/12 | XP_011520726.1 | ||
ERCC4 | XM_047433774.1 | c.1945G>A | p.Gly649Arg | missense_variant | 8/8 | XP_047289730.1 | ||
ERCC4 | XM_011522427.2 | c.1384G>A | p.Gly462Arg | missense_variant | 6/6 | XP_011520729.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERCC4 | ENST00000311895.8 | c.2734G>A | p.Gly912Arg | missense_variant | 11/11 | 1 | NM_005236.3 | ENSP00000310520 | P1 | |
ERCC4 | ENST00000682617.1 | c.2872G>A | p.Gly958Arg | missense_variant | 12/12 | ENSP00000507912 | ||||
ERCC4 | ENST00000389138.7 | n.2011G>A | non_coding_transcript_exon_variant | 6/6 | 2 | |||||
ERCC4 | ENST00000683962.1 | c.*2428G>A | 3_prime_UTR_variant, NMD_transcript_variant | 12/12 | ENSP00000506854 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152100Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000214 AC: 53AN: 247552Hom.: 1 AF XY: 0.000194 AC XY: 26AN XY: 134326
GnomAD4 exome AF: 0.0000624 AC: 91AN: 1459242Hom.: 2 Cov.: 33 AF XY: 0.0000496 AC XY: 36AN XY: 726054
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152218Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74430
ClinVar
Submissions by phenotype
not specified Uncertain:1Other:1
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 17, 2019 | - - |
not provided Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The ERCC4 p.Gly912Arg variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs150077735) and ClinVar (classified as likely benign by Invitae). The variant was identified in control databases in 58 of 264586 chromosomes (1 homozygous) at a frequency of 0.0002192 (Genome Aggregation Database March 6, 2019, v2.1.1, non-cancer). The variant was observed in the following populations: East Asian in 57 of 19170 chromosomes (freq: 0.002973) and Latino in 1 of 35058 chromosomes (freq: 0.000029), but was not observed in the African, Ashkenazi Jewish, European (Finnish), European (non-Finnish), Other, or South Asian populations. The p.Gly912 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Cockayne syndrome;C0268140:Xeroderma pigmentosum, group F;C3808988:Fanconi anemia complementation group Q Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2023 | - - |
Xeroderma pigmentosum, group F Benign:1
Likely benign, criteria provided, single submitter | clinical testing | KCCC/NGS Laboratory, Kuwait Cancer Control Center | Jul 07, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at